ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 641461 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 641461; 2) Community: the network communities that were significantly associated with the response to NSC 641461; 3) Molecule: the relationships between components within communities and NSC 641461; 4) MDR: the compounds that were significantly associated with the NSC 641461.

NSC Compound Enrichment Correlation
NSC 681635 Camptothecin Derivative 0.0273071169565314 0.52532881
NSC 681639 Camptothecin Derivative 0.0273071169565314 0.58968162
NSC 686550 Butanamide, N-(3-chloro-1,4-dioxo-2-naphthalenyl)- N-(1-oxobutyl)- 0.0273071169565314 0.085351824
NSC 693885 1-Propanone, 1-chloro-2-methyl-, O-[[(4-fluoro- 3-nitrophenyl)amino]carbonyl]oxime 0.0273071169565314 0.06028635
NSC 702158 7-epi-3,4-bis-nor-dolastatin 11 0.0273071169565314 0.050765397
NSC 706995 Entinostat 0.0273071169565314 -0.072838324
NSC 714685 Null 0.0273071169565314 -0.26562477
NSC 740564 6-(3-Aminopropyl)-9-fluoro-5,6-dihydro-2,3-dimethoxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride 0.0273071169565314 0.34810491
NSC 742410 5- fluoro-2'-deoxyuridyly-(3'->5')-3'-C-ethynylcytosine 0.0273071169565314 0.24865999
NSC 742799 3-amino-N-(4-benzylphenyl)-1H-indazole-1-carboxamide 0.0273071169565314 0.2286516
Total:68  Current:35    [First] [Prev] [Next] [Last]